Aclaris Therapeutics, Inc. - Laporan Laba Rugi (TTM)

Aclaris Therapeutics, Inc.
US ˙ NasdaqGS ˙ US00461U1051

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Aclaris Therapeutics, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 6 6 7 7 7 7 6 6 24 30 31 31 21 31 31 32 27 19 18 17
Change (%) 8.09 5.71 -3.24 3.17 -1.15 -4.79 -4.60 282.67 26.60 3.61 1.11 -31.24 45.81 -0.42 2.88 -15.42 -30.87 -5.04 -5.56
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 37 34 35 36 44 49 55 66 82 90 99 106 106 114 101 85 64 49 50 53
Change (%) -6.38 0.27 3.78 21.32 11.51 13.23 19.45 25.60 8.90 10.02 7.11 0.18 7.80 -11.18 -15.96 -25.19 -23.12 2.89 5.21
% of Revenue 613.99 531.80 504.45 541.04 636.21 717.73 853.61 1,068.78 350.80 301.74 320.39 339.41 494.48 365.60 326.09 266.36 235.57 261.99 283.84 316.22
Gross Operating Profit -31 -28 -28 -29 -37 -42 -49 -59 -59 -60 -68 -75 -85 -83 -70 -53 -37 -30 -33 -36
Change (%) -9.20 -0.99 5.51 25.43 13.87 16.15 22.64 -0.93 1.84 13.20 9.83 13.30 -1.83 -15.23 -24.30 -31.07 -17.40 7.78 11.07
% of Revenue -513.99 -431.80 -404.45 -441.04 -536.21 -617.73 -753.61 -968.78 -250.80 -201.74 -220.39 -239.41 -394.48 -265.60 -226.09 -166.36 -135.57 -161.99 -183.84 -216.22
SG&A 22 21 19 19 22 24 25 25 25 25 28 30 31 32 30 26 25 22 21 22
Change (%) -5.34 -6.69 1.55 10.90 9.48 5.39 0.82 -0.66 0.81 10.71 8.06 4.25 0.54 -6.18 -12.06 -2.07 -12.80 -3.18 2.95
% of Revenue 361.65 316.72 279.58 293.42 315.41 349.34 386.69 408.66 106.09 84.47 90.26 96.46 146.25 100.84 95.01 81.22 94.03 118.61 120.93 131.82
R&D
Change (%)
% of Revenue
OpEx 59 55 54 55 65 72 80 91 107 115 127 136 137 146 131 111 89 71 72 75
Change (%) -6.00 -2.33 2.98 17.65 10.84 10.66 13.64 18.34 7.02 10.17 7.32 1.08 6.14 -10.10 -15.08 -19.79 -20.18 1.00 4.54
% of Revenue 975.64 848.52 784.03 834.46 951.62 1,067.08 1,240.30 1,477.45 456.89 386.21 410.65 435.88 640.73 466.44 421.10 347.58 329.61 380.59 404.78 448.04
Operating Income -53 -49 -47 -49 -58 -65 -73 -85 -84 -85 -96 -105 -116 -115 -100 -79 -62 -53 -54 -58
Change (%) -7.60 -3.40 3.89 19.62 12.25 12.26 15.24 -0.85 1.53 12.46 9.32 10.70 -1.19 -12.74 -20.68 -21.56 -15.52 3.15 7.85
% of Revenue -875.64 -748.52 -684.03 -734.46 -851.62 -967.08 -1,140.30 -1,377.45 -356.89 -286.21 -310.65 -335.88 -540.73 -366.44 -321.10 -247.58 -229.61 -280.59 -304.78 -348.04
Interest Expense
Change (%)
% of Revenue
Net Income -56 -51 -64 -71 -81 -91 -81 -83 -82 -87 -96 -105 -115 -88 -77 -59 -37 -132 -130 -135
Change (%) -9.61 25.81 10.23 14.82 11.86 -10.97 2.93 -1.43 5.89 10.78 9.39 8.84 -22.81 -12.68 -24.05 -36.94 256.89 -1.41 3.41
% of Revenue -941.07 -787.03 -936.70 -1,067.07 -1,187.63 -1,343.96 -1,256.80 -1,355.98 -349.26 -292.11 -312.32 -337.90 -534.83 -283.15 -248.28 -183.29 -136.65 -705.48 -732.46 -802.03

Source: Capital IQ

Other Listings
DE:8AT
GB:0H8T
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista